Return to content in this issue

 

Long-Term Anti-Interleukin 5 Antibodies Treatment in a Patient with Chronic Eosinophilic Pneumonia

Shimizu Y1, Kurosawa M2, Sutoh Y3, Sutoh E2,3

1Division of Respiratory Medicine, Kaminakai Family Clinic, Takasaki, Gunma, Japan
2Department of Allergy and Respiratory Medicine
3Department of Surgery, Sutoh Hospital, Annaka, Gunma, Japan

J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0468

Key words: Benralizumab, Chronic eosinophilic pneumonia, Anti-interleukin 5 antibody, Mepolizumab